American Partnership for Eosinophilic Disorders Welcomes New Member to Board of Directors

April 13, 2022

(Atlanta, GA) –The Board of Directors of the American Partnership for Eosinophilic Disorders (APFED) has announced the election of a new board officer, James DeLano.  Mr. DeLano brings to APFED his extensive experience in the development and implementation of policy and compliance strategy.

Mr. DeLano is a Senior Environmental Engineer with nearly 30 years of experience in stakeholder engagement, policy development and implementation, and project and operations management.

As the father of an adolescent who has chronic disease including eosinophilic esophagitis (EoE), Mr. DeLano understands firsthand the challenges that patients and their caregivers face, particularly when it comes to diagnostic delays, adequate disease management, and the impact the disease has on quality of life.

“For more than two decades, APFED has demonstrated an unwavering commitment to serving the needs of our patient community,” shared Mr. DeLano. “It is a privilege to serve as an advocate with this organization and to help shape and implement initiatives that can improve the lives of those with eosinophil-associated diseases.”

“APFED is thrilled to have the expertise that Mr. DeLano brings to our board,” said APFED President, Dr. Wendy Book. “The DeLano family has made significant contributions to eosinophil-disease community and has long advocated for patients and families living with these diseases. We look forward to working with James to carry out APFED’s mission as we educate, advocate, and advance research.”

Founded in 2001, APFED is a non-profit organization dedicated to patients and their families coping with eosinophil-associated diseases. Eosinophil-associated diseases are chronic inflammatory conditions characterized by elevated levels of eosinophils (a type of white blood cell) in one or more specific areas of the body. The higher-than-normal number of eosinophils cause inflammation and damage to tissues and organs. These chronic diseases require lifelong treatment and symptoms may be debilitating.

“It is a pleasure to welcome James DeLano to APFED’s Board of Directors,” said APFED Executive Director, Mary Jo Strobel. “His insights, perspectives, and vast firsthand knowledge of unmet needs in our community are truly assets to our organization and to the entire patient community. We are excited to have his guidance and leadership as APFED continues to grow and expand.”

To learn more about APFED and about eosinophil-associated diseases, visit

About the American Partnership for Eosinophilic Disorders (APFED)

The American Partnership for Eosinophilic Disorders (APFED) is a non-profit organization whose mission is to passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy.